PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Title only   |   Print    Next page > 
     
T-MAXIMUM's B7-H3-Targeted Allogeneic CAR-T MT027 Receives FDA Clearance for Phase 2 Study in Brain Metastases from Lung and Breast Cancer
BEIJING , Oct. 12, 2026 /PRNewswire/ -- T-MAXIMUM PHARMACEUTICAL ("T-MAXIMUM") today announced that the U.S. Food and Drug Administration (FDA) has cleared the company to initiate a Phase ...
2026-10-12T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Three Korean Deep-Tech Firms Seek Singapore Partners in October
The pre- screened companies span smart- city positioning, AI cardiac screening and functional coatings, with Singapore meetings planned for 26 - 29 October. ...
2026-10-12T    Computer/Electronics   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Celltrion to Present New Analyses of ZYMFENTRA® (infliximab-dyyb) in Crohn's Disease and Ulcerative Colitis at ACG 2026
New data show favorable outcomes with subcutaneous infliximab following intravenous infliximab interruption, regardless of prior antibody status, in adult patients with moderate to severely active Crohn's ...
2026-10-12T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination
GUANGZHOU, China , Oct. 10, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (Nasdaq: POM), a digital healthcare company focused on advancing AI-enabled healthcare ...
2026-10-10T    Computer/Electronics   Health Care/Hospital   Internet Technology   Medical/Pharmaceuticals 
Invetech & MeMed win 2026 Good Design Award Gold for MeMed Key™
Award recognizes innovation, design excellence, and impact in Engineering Design ...
2026-10-10T    Biotechnology   Computer/Electronics   Health Care/Hospital   Infectious Disease Control 
MIDEA COMPLETES THE ACQUISITION OF ESAOTE
Midea Group marks its commitment to healthcare and innovation by completing the acquisition of Esaote   ...
2026-10-09T    Banking/Financial Service   Computer/Electronics   Electronic Components   Health Care/Hospital 
Dr. Vein, a Specialist Varicose Vein Clinic in Ho Chi Minh City, Sets Out Its Treatment Pathway for Patients Travelling from the United States
HO CHI MINH CITY, Vietnam , Oct. 9, 2026 /PRNewswire/ -- Dr. Vein Clinic, a medical facility in central Ho Chi Minh City specializing in the examination and treatment of varicose veins, has set out the ...
2026-10-09T    Health Care/Hospital   Medical/Pharmaceuticals   Travel 
India Mental Health Alliance (IMHA) champions lived experience as central to shaping mental healthcare practice, service design and policy
NEW DELHI , Oct. 9, 2026 /PRNewswire/ -- On the occasion of World Mental Health Day (10th October), the India Mental Health Alliance (IMHA), a cross-sectoral network of 400 organisations from 30 Indian ...
2026-10-09T    Health Care/Hospital   Medical/Pharmaceuticals   Publishing/Information Service 
Antengene to Present Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 2026
SHANGHAI and HONG KONG , Oct. 9, 2026 /PRNewswire/ -- Antengene Corporation Limited  ( "Antengene" , SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated ...
2026-10-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development
Lakshmi Srinivasan, PhD, former Executive Director and Head of Oncology Translational Medicine at Moderna, and Brandon Coder, PhD, former Research & Early Translational Lead, Cancer Vaccines at Moderna, ...
2026-10-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.